ru24.pro
News in English
Июнь
2024

Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA

0
Biocon said that its subsidiary Biocon Biologics has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new multi-product monoclonal antibodies (mAbs) drug substance facility at Bengaluru.